• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Experts say the indictment of former Trump campaign associates has made the lobbying firms of Washington, D.C.'s K Street "very nervous." There is evidence, they say, that firms on both sides of the political spectrum have been violating federal regulations for years.
    Politics

    Federal lobbying hit record $4.4 billion in 2024

    Gabe Kaminsky -
    February 18, 2025 6:00 am
    0
    A research assistant with the David Geffen School of Medicine at UCLA carries a portable cooler marked with a biohazard label past the Ronald Reagan UCLA Medical Center in Los Angeles, Thursday, Feb. 19, 2015. (AP Photo/Damian Dovarganes)
    Investigations

    News outlets circulated drug research from nonprofit group without disclosing its pharmaceutical industry ties

    Robert Schmad -
    February 12, 2025 3:56 pm
    0
    Pharmacies are fed up with PBMs. Here’s what reforms might be coming
    Healthcare

    Pharmacies are fed up with PBMs. Here’s what reforms might be coming

    Emily Hallas -
    February 10, 2025 8:00 am
    0
    Robert F. Kennedy Jr., President Donald Trump's choice to be the secretary of Health and Human Services, arrives to testify before the Senate Finance Committee during his confirmation hearing at the Capitol in Washington, Wednesday, Jan. 29, 2025.
    Faith, Freedom, and Self-Reliance

    Let Medicare cover weight loss drugs to make America healthy

    Saul Anuzis -
    February 9, 2025 8:00 am
    0
    FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
    Healthcare

    FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

    Associated Press -
    February 1, 2025 12:48 pm
    0
    Purdue Pharma, Sackler family agree to $7 billion settlement over opioid crisis
    Healthcare

    Purdue Pharma, Sackler family agree to $7 billion settlement over opioid crisis

    Jack Birle -
    January 23, 2025 2:00 pm
    0
    Drugmakers hike prices to start year as threats to industry loom
    Healthcare

    Drugmakers hike prices to start year as threats to industry loom

    Gabrielle M. Etzel -
    January 2, 2025 10:44 am
    0
    Sen. Elizabeth Warren (D-CA).
    Healthcare

    Warren and Hawley join forces for bill that would force health insurers to sell off pharmacies

    Andi Shae Napier -
    December 11, 2024 12:49 pm
    0
    Guthrie will use key panel to roll back Biden Medicare changes and oversee agencies
    Healthcare

    Guthrie will use key panel to roll back Biden Medicare changes and oversee agencies

    Gabrielle M. Etzel -
    December 10, 2024 3:54 pm
    0
    Close-up of American dollars with calculator and pens over documents on table.
    News

    Amgen plans $1B investment in North Carolina

    David Beasley | The Center Square contributor -
    December 6, 2024 12:08 pm
    0
    1...101112...157Page 11 of 157
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.